title: Effect of retinoids and 1,25(OH)2 vitamin D3 bound to their plasma transport proteins on growth and differentiation of HL-60 cells.
abstract: We have compared the effect of physiological and pharmacological concentrations of retinoids and 1,25(OH)2 vitamin D3 bound to their plasma transport proteins upon the proliferation and differentiation of HL-60 cells. Concentrations of chylomicron remnant retinyl ester similar to that obtained in plasma after a vitamin A-rich meal reduced the proliferation in more than 50% of HL-60 cells. Pharmacological concentrations of chylomicron remnant retinyl ester completely blocked the proliferation of the cells, and induced differentiation in 60% of the cells after 5 days. Physiological and pharmacological concentrations of retinoic acid bound to albumin had comparable effects. In contrast to earlier published data, which have been obtained with retinoids dissolved in ethanol, our results suggest that physiological and pharmacological concentrations of retinol (i.e. retinyl esters in chylomicron remnants) are as active as retinoic acid in reduction of proliferation and induction of differentiation of HL-60 cells. Physiological concentrations of 1,25(OH)2 vitamin D3 bound to vitamin D-binding protein (DBP) and retinol bound to retinol-binding protein had only a small effect on differentiation and proliferation of HL-60 cells.
authors.affiliation: Institute for Nutrition Research, School of Medicine, University of Oslo, Norway.
authors.forename: M
authors.initials: M
authors.lastname: Botilsrud
authors.forename: I
authors.initials: I
authors.lastname: Holmberg
authors.forename: K O
authors.initials: KO
authors.lastname: Wathne
authors.forename: H K
authors.initials: HK
authors.lastname: Blomhoff
authors.forename: K R
authors.initials: KR
authors.lastname: Norum
authors.forename: R
authors.initials: R
authors.lastname: Blomhoff
mesh_terms: D002117:Calcitriol / Q000378:metabolism / Q000494:pharmacology*; D002352:Carrier Proteins / Q000378:metabolism*; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000473:pathology*; D012176:Retinoids / Q000378:metabolism / Q000494:pharmacology*; D012177:Retinol-Binding Proteins / Q000378:metabolism; D054839:Retinol-Binding Proteins, Plasma; D012709:Serum Albumin / Q000378:metabolism; D014212:Tretinoin / Q000378:metabolism / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D014801:Vitamin A / Q000378:metabolism / Q000494:pharmacology; D014809:Vitamin D-Binding Protein / Q000378:metabolism
chemical_list: D002352:Carrier Proteins; D012176:Retinoids; D012177:Retinol-Binding Proteins; D054839:Retinol-Binding Proteins, Plasma; D012709:Serum Albumin; D014809:Vitamin D-Binding Protein; D014801:Vitamin A; D014212:Tretinoin; D002117:Calcitriol